Trial Details
COMPLETEDBasic Information
| Clinical ID | c2193 |
|---|---|
| Identifier | NCT03854305 |
| Trial Title | Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: PRV-6527|DRUG: Placebo |
Participant Information
| Sponsor | Provention Bio, Inc. |
|---|---|
| City | Innsbruck |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-03-20 |
|---|---|
| Primary Completion Date | 2019-08-13 |
| Completion Date | 2019-08-13 |